vs
BANCFIRST CORP（BANF）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是BANCFIRST CORP的1.1倍（$197.9M vs $181.0M），BANCFIRST CORP净利率更高（32.9% vs 6.7%，领先26.2%），REPLIGEN CORP同比增速更快（13.6% vs 11.1%），BANCFIRST CORP自由现金流更多（$237.0M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.5%）
BancFirst Corporation是总部位于美国俄克拉荷马州的金融服务控股公司，旗下共运营三家附属银行：俄克拉荷马州特许银行BancFirst，以及得克萨斯州特许的Pegasus银行和沃辛顿银行，为两地市场提供多元金融服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BANF vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$181.0M
营收增速更快
RGEN
高出2.6%
11.1%
净利率更高
BANF
高出26.2%
6.7%
自由现金流更多
BANF
多$219.4M
$17.6M
两年增速更快
RGEN
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $181.0M | $197.9M |
| 净利润 | $59.5M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 41.6% | 9.0% |
| 净利率 | 32.9% | 6.7% |
| 营收同比 | 11.1% | 13.6% |
| 净利润同比 | 5.3% | 143.9% |
| 每股收益（稀释后） | $1.75 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BANFRGEN
| Q4 25 | $181.0M | $197.9M | ||
| Q3 25 | $175.5M | $188.8M | ||
| Q2 25 | $169.3M | $182.4M | ||
| Q1 25 | $164.8M | $169.2M | ||
| Q4 24 | $162.9M | $174.1M | ||
| Q3 24 | $163.7M | $154.9M | ||
| Q2 24 | $153.8M | $154.1M | ||
| Q1 24 | $151.0M | $151.3M |
净利润BANFRGEN
| Q4 25 | $59.5M | $13.3M | ||
| Q3 25 | $62.7M | $14.9M | ||
| Q2 25 | $62.3M | $14.9M | ||
| Q1 25 | $56.1M | $5.8M | ||
| Q4 24 | $56.5M | $-30.3M | ||
| Q3 24 | $58.9M | $-654.0K | ||
| Q2 24 | $50.6M | $3.3M | ||
| Q1 24 | $50.3M | $2.1M |
毛利率BANFRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率BANFRGEN
| Q4 25 | 41.6% | 9.0% | ||
| Q3 25 | 45.0% | 8.9% | ||
| Q2 25 | 47.1% | 7.6% | ||
| Q1 25 | 43.1% | 3.9% | ||
| Q4 24 | 44.2% | -17.7% | ||
| Q3 24 | 45.2% | -5.1% | ||
| Q2 24 | 42.4% | 1.0% | ||
| Q1 24 | 42.5% | 1.3% |
净利率BANFRGEN
| Q4 25 | 32.9% | 6.7% | ||
| Q3 25 | 35.7% | 7.9% | ||
| Q2 25 | 36.8% | 8.2% | ||
| Q1 25 | 34.0% | 3.4% | ||
| Q4 24 | 34.7% | -17.4% | ||
| Q3 24 | 36.0% | -0.4% | ||
| Q2 24 | 32.9% | 2.2% | ||
| Q1 24 | 33.3% | 1.4% |
每股收益（稀释后）BANFRGEN
| Q4 25 | $1.75 | $0.24 | ||
| Q3 25 | $1.85 | $0.26 | ||
| Q2 25 | $1.85 | $0.26 | ||
| Q1 25 | $1.66 | $0.10 | ||
| Q4 24 | $1.68 | $-0.55 | ||
| Q3 24 | $1.75 | $-0.01 | ||
| Q2 24 | $1.51 | $0.06 | ||
| Q1 24 | $1.50 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.9B | $2.1B |
| 总资产 | $14.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BANFRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务BANFRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BANFRGEN
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.8B | $2.1B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.7B | $2.0B | ||
| Q4 24 | $1.6B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.5B | $2.0B |
总资产BANFRGEN
| Q4 25 | $14.8B | $2.9B | ||
| Q3 25 | $14.2B | $2.9B | ||
| Q2 25 | $14.0B | $2.9B | ||
| Q1 25 | $14.0B | $2.9B | ||
| Q4 24 | $13.6B | $2.8B | ||
| Q3 24 | $13.3B | $2.8B | ||
| Q2 24 | $12.7B | $2.9B | ||
| Q1 24 | $12.6B | $2.8B |
负债/权益比BANFRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $285.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $237.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 130.9% | 8.9% |
| 资本支出强度资本支出/营收 | 26.7% | 4.1% |
| 现金转化率经营现金流/净利润 | 4.79× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $430.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BANFRGEN
| Q4 25 | $285.3M | $25.7M | ||
| Q3 25 | $75.4M | $48.1M | ||
| Q2 25 | $78.1M | $28.6M | ||
| Q1 25 | $77.0M | $15.0M | ||
| Q4 24 | $261.2M | $39.2M | ||
| Q3 24 | $77.6M | $49.3M | ||
| Q2 24 | $100.2M | $42.2M | ||
| Q1 24 | $66.3M | $44.7M |
自由现金流BANFRGEN
| Q4 25 | $237.0M | $17.6M | ||
| Q3 25 | $63.7M | $43.4M | ||
| Q2 25 | $64.4M | $21.5M | ||
| Q1 25 | $65.6M | $11.4M | ||
| Q4 24 | $224.5M | $33.6M | ||
| Q3 24 | $72.4M | $42.3M | ||
| Q2 24 | $94.1M | $37.4M | ||
| Q1 24 | $56.1M | $36.4M |
自由现金流率BANFRGEN
| Q4 25 | 130.9% | 8.9% | ||
| Q3 25 | 36.3% | 23.0% | ||
| Q2 25 | 38.0% | 11.8% | ||
| Q1 25 | 39.8% | 6.8% | ||
| Q4 24 | 137.8% | 19.3% | ||
| Q3 24 | 44.2% | 27.3% | ||
| Q2 24 | 61.2% | 24.3% | ||
| Q1 24 | 37.1% | 24.0% |
资本支出强度BANFRGEN
| Q4 25 | 26.7% | 4.1% | ||
| Q3 25 | 6.7% | 2.5% | ||
| Q2 25 | 8.1% | 3.9% | ||
| Q1 25 | 6.9% | 2.1% | ||
| Q4 24 | 22.5% | 3.2% | ||
| Q3 24 | 3.2% | 4.5% | ||
| Q2 24 | 3.9% | 3.1% | ||
| Q1 24 | 6.8% | 5.5% |
现金转化率BANFRGEN
| Q4 25 | 4.79× | 1.93× | ||
| Q3 25 | 1.20× | 3.23× | ||
| Q2 25 | 1.25× | 1.92× | ||
| Q1 25 | 1.37× | 2.57× | ||
| Q4 24 | 4.62× | — | ||
| Q3 24 | 1.32× | — | ||
| Q2 24 | 1.98× | 12.70× | ||
| Q1 24 | 1.32× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
